biopharmaceuticals

Increasing Complexity of Pharma Logistics

The pharmaceutical industry requires reliable and innovative partners who can flexibly adapt to its changing demands.

E. Coli Bioprocessing: Pioneering Advances in Biotechnology

Download this complimentary Expert Insights eBook today!

Fujifilm Invests $1.6 Billion for Cell Culture Expansion

Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Webinar Series: The Future of Scientific Product Innovation and Manufacturing in the Life Sciences Industry

Driving Innovation and Extending Its Global Reach

Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."

Rentschler Biopharma Extends Japanese Pact

German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with Summit Pharmaceuticals International (SPI), a wholly owned subsidiary of Sumitomo.

Boehringer Ingelheim Buys ViraTherapeutics

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

J&J Expects Actelion Deal to Close This Week

Roquette to Launch New Biopharmaceutical Brands

Patheon and Amgen in Toll Manufacturing Pact

Lonza Expands UK Mammalian Production

Shire to Acquire Baxalta for $32 Billion

Merck-Pfizer Alliance Joins Syndax on Ovarian Cancer

Amgen Takes Back Bone Drugs from GSK

Baxalta Gets EU Nod for Hemophilia Treatment

Bio On Demand

Innovative Medicine with Rising Productivity Targets

Chances and Hurdles for Biosimilars

Amgen to Buy Dezima Pharma, Collaborates with Xencor

Novartis and Amgen Partner on Alzheimer’s and Migraine

United Therapeutics Sells Priority Review Voucher to AbbVie

Aveo Licenses Antibody to Novartis for Treatment of Cachexia

Where Cleanliness Becomes a Challenge

Merck Serono and Illumina in Oncology Diagnostics Pact

Arrowhead Buys Novartis’ RNAi R&D Portfolio

XL-protein Licenses Technology to MSD

Lonza and Tigenix Sign Toll Manufacture Agreement

Discovering the Future of Pharma

Merck Serono and Mersana Collaborate on Antibody Drug Conjugates

Preparing for Tomorrow’s Pharmaceutical Challenges

Preparing for Tomorrow’s Pharmaceutical Challenges

Merck Serono Gains Rights to Market EEVA Test

Merck Serono Names Meeta Gulyani to Pharma Executive Committee

Merck Serono in Spanish Drug Development Pact